Scholar Rock Holding (SRRK) EBITDA (2017 - 2026)

Scholar Rock Holding (SRRK) recorded quarterly EBITDA of -$104.9 million in Q1 2026, down 15.31% quarter-over-quarter from -$91.0 million in Q4 2025, and down 40.35% on a YoY basis from -$175.9 million in Q1 2025.

Scholar Rock Holding (SRRK) EBITDA (2017 - 2026) Analysis & Trends

Scholar Rock Holding's EBITDA history runs 10 years deep, the most recent figure standing at -$104.9 million for Q1 2026.

  • In Q1 2026, EBITDA fell 40.35% year-over-year to -$104.9 million; the TTM figure through Mar 2026 stood at -$408.2 million (down 54.62% YoY), while the FY2025 annual figure was -$378.0 million, down 53.52% from the prior year.
  • EBITDA was -$104.9 million for Q1 2026 at Scholar Rock Holding, down from -$91.0 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of -$8.1 million in Q1 2022 to a low of -$110.1 million in Q2 2025.
  • Historically, EBITDA has averaged -$60.5 million across 5 years, with a median of -$57.0 million in 2024.
  • The sharpest annual moves came in 2022 and 2023: EBITDA jumped 70.82% in 2022, then sank 381.27% in 2023.
  • A 5-year view of EBITDA shows it stood at -$39.2 million in 2022, then retreated by 17.37% to -$46.0 million in 2023, then slumped by 44.36% to -$66.4 million in 2024, then tumbled by 36.98% to -$91.0 million in 2025, then retreated by 15.31% to -$104.9 million in 2026.
  • The last three EBITDA figures came in at -$104.9 million (Q1 2026), -$91.0 million (Q4 2025), and -$102.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -26.92 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -13.63 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -19.70 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -3.82 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -14.44 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -752,618.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.14 Bn
9 Abivax 91.96 Bn 91.96 Bn - -65.83 Mn
10 Scholar Rock Holding 6.03 Bn 5.55 Bn - -104.91 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -104.91 Mn
Dec 31, 2025 -90.99 Mn
Sep 30, 2025 -102.16 Mn
Jun 30, 2025 -110.10 Mn
Mar 31, 2025 -74.75 Mn
Dec 31, 2024 -66.42 Mn
Sep 30, 2024 -64.30 Mn
Jun 30, 2024 -58.51 Mn
Mar 31, 2024 -57.00 Mn
Dec 31, 2023 -46.01 Mn
Sep 30, 2023 -42.32 Mn
Jun 30, 2023 -37.66 Mn
Mar 31, 2023 -38.82 Mn
Dec 31, 2022 -39.20 Mn
Sep 30, 2022 -44.15 Mn
Jun 30, 2022 -43.93 Mn
Mar 31, 2022 -8.07 Mn
Dec 31, 2021 -35.95 Mn
Sep 30, 2021 -37.52 Mn
Jun 30, 2021 -30.72 Mn